Drouillard, Donovan
Poimenidou, Maria
Davies, Marissa
McAllister, Donna
Clarke, William R.
Hwang, Samuel T.
Peterson, Francis C.
Volkman, Brian F.
Dwinell, Michael B.
Funding for this research was provided by:
National Institutes of Health (F30 CA291095)
National Institutes of Health (R44 AR081754)
Article History
Received: 6 August 2025
Accepted: 27 November 2025
First Online: 19 December 2025
Declarations
:
: Preclinical experimental procedures involving animals were conducted in accordance with the NIH Guide for the Care and Use of Laboratory Animals and were formally reviewed and approved by the Medical College of Wisconsin Institutional Animal Care and Use Committee (IACUC) (approval No. AUA000076).
: The studies completed solely utilize preclinical approaches.
: MBD, BFV, FCP, STH, WFC have financial interests in Protein Foundry, LLC and XLock Biosciences, Inc which produced CCL20LD. The remaining authors have no conflicts to disclose.